How does an automated experimental platform reshape the future of biomanufacturing?

Preface

The 'Moore's Law' of biomanufacturing may be hidden within this closed loop.

In today's rapid advances in biomedicine and synthetic biology, we are often amazed by the atomic-level accuracy of AI in predicting protein structures and excited by the infinite possibilities of generative models designing entirely new functional proteins from scratch.

However, an unavoidable 'scissors gap' is emerging: the computational design speed of the 'AI brain' is exponentially outpacing the verification throughput of 'wet experiments.'

While dry experiments can generate thousands of candidate sequences in the cloud within a second, traditional wet labs are still stuck in the 'graduate student workshop' era—pipettes, petri dishes, chromatography columns, repeating endlessly.

How can the design speed of the digital world be transformed into material reality in the physical world? The answer points to a core hub—a fully automated experimental platform.

The end of the manual workshop: Why automation is essential?

To understand the value of automated experimental platforms, one must first recognize the 'ceiling' of traditional models.

Traditional biological experiments are highly nonlinear, multi-variable, and strongly dependent on experience. Even the best experimenters struggle to handle hundreds of conditions in parallel. This not only limits throughput but also hides three deep risks:

01 Low reproducibility crisis:

Differences in personal operations and daily physiological states make the variance of experimental data difficult to converge. The same SOP may yield drastically different results in different hands, which is fatal for AI models that require high-quality data.

02 Dimensional disaster:

Promoter strength, RBS sequences, reaction temperature, inducer concentration, host metabolic stress... the combination of synthetic biology component parameters can easily reach tens of thousands. Relying on humans to traverse all conditions is like finding a needle in a haystack.

03 Innovator's time trap:

Top scientists' core abilities lie in proposing hypotheses and designing strategies, not spending 80% of their time on repetitive pipetting. This mismatch severely slows down the pace of innovative iteration.

The essence of an automated experimental platform is to transform this 'artisanal' operation into an 'industrialized' assembly line. It is not simply 'machines replacing humans,' but rather building an integrated dry and wet data production system.

Architecture analysis: More important than 'robotic arms' is the 'scheduling brain'

An Analysis of the Architecture of an Automated Testing Platform

A mature automated laboratory platform is far more than just a liquid handling workstation or a conveyor belt. It is a precise system with integrated hardware and software, advancing layer by layer:

Execution Layer: Integrates multi-axis robotic arms, high-precision liquid handling systems, multifunctional microplate readers, incubators, automated clone pickers, and other “hard muscles” to achieve precise control from nanoliter droplets to liter-scale fermentation.

Sensing Layer: Monitors parameters such as cell growth, fluorescence intensity, pH, and dissolved oxygen in real-time through sensors and visual recognition, replacing human observation and ensuring spatial and temporal alignment of every data point.

Scheduling Hub: This is the soul of the platform. A set of intelligent software dynamically schedules hundreds of parallel tasks, optimizes equipment utilization, handles unexpected anomalies, and keeps randomly introduced experimental workflows organized.

Data Foundation: Standardizes heterogeneous data generated by all equipment and automatically links it with experimental design metadata, forming clean datasets ready for direct AI analysis.

Only when these four layers are tightly integrated can an “isolated instrument” be upgraded to an “unmanned laboratory,” and scattered electronic records evolve into structured data assets.

The Power of the Closed Loop: When design, build, test, and learn are integrated

The ultimate form of an automated laboratory platform is a fully automated closed loop that works with AI models to construct the "Design-Build-Test-Learn" (DBTL) cycle. This is precisely the core battlefield where AI protein design companies break through bottlenecks and build competitive barriers.

Here is a highly representative practical example—MatwingsVenus™ (Xiaowu™) automated laboratory platform developed by Shanghai Tiamat Technology.

Automated biological experimentation platform

MatwingsVenus™ ™ is not simply an automated device integration, but a closed-loop system that deeply integrates AI protein design models with high-throughput wet experiment validation. Its operating logic directly addresses industry pain points:

Design side: Matwings Technology's protein large language model performs millions of calculations in the digital space, generating high-quality mutant sequences targeting specific functional targets such as high activity and high thermal stability.

Construction and testing end: sequence commands are directly sent to the MatwingsVenus™ ™ platform, and the robotic arm immediately completes the fully automated operation from gene cloning, transformation, cultivation to functional screening. The platform can precisely characterize thousands of mutants within weeks, with data automatically returned.

Learning End: High-quality measured data is returned to AI models for iterative training, rapidly improving prediction accuracy for specific tasks.

The value of this model has already surpassed the primary goal of "saving personnel and improving efficiency." It restructures the iterative model of ™ protein design: a previously "AI design-human testing-feedback" cycle could take months, but on the MatwingsVenus™ platform, this cycle is compressed to weeks or even less, with a dramatic leap in data quality.

This is exactly the significance of automated experimental platforms as the "unlocking key": they enable AI-designed virtual sequences to quickly receive real feedback in the physical world, turning "intelligence" into "functionality."

Conclusion: The Call of New Infrastructure

Automated experimental platforms are transforming from the "luxury configurations" of leading pharmaceutical companies into the "standard chassis" of every leading biotech company. It is not only a productivity tool but also a strategic fulcrum that determines how far AI models can go and how deep the data moat can be dug.

In the future, the measure of a biotech company's value may no longer be the number of experienced lab technicians it has, but the data throughput rate of its automated platform and the iteration efficiency of the wet-dry closed-loop process.

When cold manipulators tirelessly explore the design space of life, and every drop of experimental liquid is assigned a data dimension, we are one step closer to precisely controlling proteins and customizing the future of life.

On this road to a new era of biomanufacturing, building a unique automated experimental system is no longer a multiple-choice question, but a mandatory question that determines whether one can secure a ticket to the next era.